Using Financing to Improve Tuberculosis Outcomes for Private Sector Patients
29 April 2019
Despite widespread use of private providers for the diagnosis and treatment of tuberculosis (TB), the quality of care in the private sector is hindering efforts to improve TB outcomes. TB remains the ninth leading cause of death worldwide, and efforts to drive improvements have been largely focused on the public sector. Across the top 30 high-burden countries (HBCs), the private sector plays a significant role in the diagnosis and treatment of patients with both drug-sensitive and drug-resistant TB. Yet quality of TB care provided in the private sector is inconsistent and inadequate, negatively influencing TB outcomes.
ThinkWell, with the support of the Bill & Melinda Gates Foundation, has released a report offering a global review of high-level programmatic challenges seen in private sector TB care and the ways in which financing mechanisms can be used to address these challenges, drawing from lessons learned from other health areas. By identifying gaps in the status quo and proposing a theory of change to systematically influence how TB care is delivered in the private sector, there is significant opportunity to harness the private sector for quality service delivery. Catalytic investment to support governments in using strategic purchasing mechanisms, coupled with deliberate investment to purchase high-quality TB services from targeted private providers in alignment with national quality and regulatory standards, will lead to improved TB outcomes.
To read our full report and recommendations, click here.